<DOC>
	<DOCNO>NCT00849537</DOCNO>
	<brief_summary>In study , regress proliferative diabetic retinopathy , severe , severe moderate non-prolifrative diabetic retinopathy patient go cataract surgery , underwent complete eye examination , OCT , FAG color photography 2 week prior operation . All patient divide two : 1 ) control group ( Phyco , PCIOL ) , 2 ) triamcinolone treatment group ( Phaco PCIOL+IVT ) . One month surgery complete eye examination do especially ; IOP endophthalmitis . A 6 month follow-up do two group diabetic retinopathy progression check .</brief_summary>
	<brief_title>The Effect Intravitral Injection Triamcinolone Combined With Cataract Surgery ( Phacoemulsification ) Diabetic Macular Edema Diabetic Retinopathy</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Diabetic patient nonproliferative diabetic retinopathy regress PDR Uncontrolled HTN History glaucoma Active PDR NVI TRD Any ophthalmic operation Renal problem ( cr &gt; 3 ) CVA Uveitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Triamcinolon</keyword>
	<keyword>Cataract</keyword>
	<keyword>Diabetic retinopathy</keyword>
	<keyword>non-proliferative retinopathy</keyword>
</DOC>